FGF23 in Cardiovascular Disease: Innocent Bystander or Active Mediator?

Frontiers in Endocrinology - Switzerland
doi 10.3389/fendo.2018.00351
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Mesenteric Fat in Crohn's Disease: A Pathogenetic Hallmark or an Innocent Bystander?

Gut
Gastroenterology
2007English

Actinobaculum Schaalii- Invasive Pathogen or Innocent Bystander? A Retrospective Observational Study

BMC Infectious Diseases
Infectious Diseases
2011English

Leukotriene Receptor Antagonist Therapy and Churg-Strauss Syndrome: Culprit or Innocent Bystander?

Thorax
PulmonaryRespiratory Medicine
2008English

Patent Foramen Ovale in COPD and Hypoxia: Innocent Bystander or Novel Therapeutic Target?

Chronic Obstructive Pulmonary Diseases
PulmonaryRespiratory Medicine
2014English

The Intercoronary Pillar: Not Necessarily an Innocent Bystander

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2019English

FGF23 Beyond Mineral Metabolism: A Bridge to Cardiovascular Disease

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2011English

Is the Right Ventricular an Innocent Bystander in Pulmonary Resection?

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2019English

Chiari Network – Just an Innocent Bystander or Can Have Serious Impact on Clinical Outcomes

American Journal of Internal Medicine
2019English

Cirrhotic Cardiomyopathy After Transplantation: Neither the Transient Nor Innocent Bystander

Hepatology
MedicineHepatology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy